CMS: CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 1st Interim Announcement

CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 1st Interim Announcement
In the period from March 26, 2024 until and including March 28, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 75,290 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2021.
The aggregate number of shares bought back each day during the period from March 26, 2024 until and including March 28, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:
 

The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including March 28, 2024 amounts to 75,290 shares.
Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html .
The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, April 02, 2024

CompuGroup Medical SE & Co. KGaA
The general partner